Patents by Inventor Jason M. Stout

Jason M. Stout has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10724009
    Abstract: Nucleic acid molecules from cannabis have been isolated and characterized and encode polypeptides having cannabichromenic acid synthase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: July 28, 2020
    Assignee: National Research Council of Canada (NRC)
    Inventors: Jonathan E. Page, Jason M. Stout
  • Publication number: 20190382734
    Abstract: Nucleic acid molecules from cannabis have been isolated and characterized and encode polypeptides having cannabichromenic acid synthase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
    Type: Application
    Filed: June 17, 2019
    Publication date: December 19, 2019
    Inventors: Jonathan E. Page, Jason M. Stout
  • Patent number: 10364416
    Abstract: Nucleic acid molecules from cannabis have been isolated and characterized and encode polypeptides having cannabichromenic acid synthase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: July 30, 2019
    Assignee: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Jonathan E. Page, Jason M. Stout
  • Publication number: 20170211049
    Abstract: Nucleic acid molecules from cannabis have been isolated and characterized and encode polypeptides having cannabi-chromenic acid synthase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
    Type: Application
    Filed: June 29, 2015
    Publication date: July 27, 2017
    Inventors: Jonathan E. Page, Jason M. Stout
  • Patent number: 9546362
    Abstract: Polypeptides having alkanoyl-CoA activity have been identified and characterized, as have nucleic acids encoding these polypeptides. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds in organisms. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: January 17, 2017
    Assignees: National Research Council of Canada, University of Saskatchewan
    Inventors: Jonathan E. Page, Jason M. Stout
  • Publication number: 20140141476
    Abstract: Polypeptides having alkanoyl-CoA activity have been identified and characterized, as have nucleic acids encoding these polypeptides. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds in organisms. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
    Type: Application
    Filed: July 13, 2012
    Publication date: May 22, 2014
    Applicants: UNIVERSITY OF SASKATCHEWAN, NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Jonathan E. Page, Jason M. Stout